Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy
Authors:
- Christine Í DaliCDChristine Í Dali
- Norman W. BartonNBNorman W. Barton
- Mohamed H. FarahMFMohamed H. Farah
- Mihai MoldovanMihai Moldovan
- Jan‐Eric MånssonJMJan‐Eric Månsson
- Nitin NairNNNitin Nair
- Morten DunøMDMorten Dunø
- Lotte RisomLRLotte Risom
- Hongmei CaoHCHongmei Cao
- Luying PanLPLuying Pan
- Marcia Sellos‐MouraMSMarcia Sellos‐Moura
- Andrea M. CorseACAndrea M. Corse
Open Access
- 27 March 2015
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 2 (5) , 518-533
Abstract
Objective: Metachromatic leukodystrophy (MLD) is an autosomal recessive lysosomal storage disorder due to deficient activity of arylsulfatase A (ASA) that causes accumulation of sulfatide and lysosulfatide. The disorder is associated with demyelination and axonal loss in the central and peripheral nervous systems. The late infantile form has an early‐onset, rapidly progressive course with severe sensorimotor dysfunction. The relationship between the degree of nerve damage and (lyso)sulfatide accumulation is, however, not established.Methods: In 13 children aged 2–5 years with severe motor impairment, markedly elevated cerebrospinal fluid (CSF) and sural nerve sulfatide and lysosulfatide levels, genotype, ASA mRNA levels, residual ASA, and protein cross‐reactive immunological material (CRIM) confirmed the diagnosis. We studied the relationship between (lyso)sulfatide levels and (1) the clinical deficit in gross motor function (GMFM‐88), (2) median and peroneal nerve motor and median and sural nerve sensory conduction studies (NCS), (3) median and tibial nerve somatosensory evoked potentials (SSEPs), (4) sural nerve histopathology, and (5) brain MR spectroscopy.Results: Eleven patients had a sensory‐motor demyelinating neuropathy on electrophysiological testing, whereas two patients had normal studies. Sural nerve and CSF (lyso)sulfatide levels strongly correlated with abnormalities in electrophysiological parameters and large myelinated fiber loss in the sural nerve, but there were no associations between (lyso)sulfatide levels and measures of central nervous system (CNS) involvement (GMFM‐88 score, SSEP, and MR spectroscopy).Interpretation: Nerve and CSF sulfatide and lysosulfatide accumulation provides a marker of disease severity in the PNS only; it does not reflect the extent of CNS involvement by the disease process. The magnitude of the biochemical disturbance produces a continuously graded spectrum of impairments in neurophysiological function and sural nerve histopathology.Keywords
Funding Information
- Danish Medical Research Council
- Lundbeck Foundation
- Novo Nordisk Foundation
This publication has 42 references indexed in Scilit:
- Brain N -acetylaspartate levels correlate with motor function in metachromatic leukodystrophyNeurology, 2010
- The Role and Metabolism of Sulfatide in the Nervous SystemMolecular Neurobiology, 2008
- Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic optionsActa Paediatrica, 2008
- Enzyme, cell and gene‐based therapies for metachromatic leukodystrophyJournal of Inherited Metabolic Disease, 2007
- Late onset MLD with normal nerve conduction associated with two novel missense mutations in the ASA geneJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Neurophysiology and MRI in late-infantile metachromatic leukodystrophyPediatric Neurology, 1999
- Morphometric studies on the human sural nerve.1990
- Review Article: The Use of Somatosensory Evoked Potentials in Infants and ChildrenJournal of Child Neurology, 1989
- A MORPHOMETRIC STUDY ON SURAL NERVES IN METACHROMATIC LEUCODYSTROPHYBrain, 1987
- Pathology of peripheral nerves in metachromatic leucodystrophyJournal of the Neurological Sciences, 1982